Answers are grounded in this paper and cite their sources.
Propionic acid derivative 8, which was designed and synthesized based on putative pharmacophores of known PPARgamma- and PPARalpha-selective compounds, exhibits potent dual PPARalpha/gamma agonist activity as demonstrated by in vitro binding and dose overlap in the newly introduced EOB mouse model for glucose lowering and lipid/cholesterol homeostasis.
No takes yet. Share an insight, caveat, or question.
Brooks et al. (2001) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: